Bluejay Diagnostics, Inc. Common Stock
BJDX XNAS
$0.85
-0.03 (-3.88%)
▼
15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$878.4K
About Bluejay Diagnostics, Inc. Common Stock
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $0 | $-2,324,013 | $-1.12 |
| Q1 2026 | $0 | $-1,919,241 | $-1.95 |
| FY 2025 | $0 | $-6,848,483 | $-15.25 |
| Q3 2025 | $0 | $-1,597,632 | $-1.01 |
TickerDaily Coverage
Why Is Bluejay Diagnostics, Inc. Common Stock (BJDX) Stock Up 50.4% Today?
Penny Stocks
Marcus Rivera · Jul 7, 2026
Bluejay Diagnostics (BJDX) stock exploded 50.4% higher Tuesday, July 7, 2026, after announcing the...
Why Is Bluejay Diagnostics, Inc. Common Stock (BJDX) Stock Up 60.5% Today?
Penny Stocks
Marcus Rivera · Jul 6, 2026
Bluejay Diagnostics (BJDX) exploded 60.5% Monday, July 6, 2026, after announcing the closing of a...
Why Is Bluejay Diagnostics, Inc. Common Stock (BJDX) Stock Up 177.5% Today?
Market News
Alex Chen · Jun 2, 2026
Bluejay Diagnostics stock exploded higher Tuesday after the company announced an abstract...
View All Coverage →
Get BJDX Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Bluejay Diagnostics, Inc. Common Stock.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.